We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Peripheral Blood Mononuclear Cells for Biomarker Research
Product News

Peripheral Blood Mononuclear Cells for Biomarker Research

Peripheral Blood Mononuclear Cells for Biomarker Research
Product News

Peripheral Blood Mononuclear Cells for Biomarker Research


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Peripheral Blood Mononuclear Cells for Biomarker Research"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

AMSBIO has introduced the ImmunoPure™ range of peripheral blood mononuclear cells (PBMCs) supplied in proprietary reagents that ensure high survival and recovery rates.

ImmunoPure™ PBMCs are a variety of immune cells derived from the peripheral blood of normal healthy human adult donors collected at IRB-approved blood banks.

Seven types are currently available and consist of a variety of immune cells derived from the peripheral blood of normal adults, thereby qualifying them for a diverse number of cell-based experiments.

The lymphocyte and monocyte fractions are isolated from whole blood using apheresis, a technology in which the blood of a donor is passed through an apparatus that separates out these fractions, and returns the remainder to the donor's circulation.

After depletion of granulocytes, and red blood cell these PBMCs are immediately cryopreserved using proprietary reagents to ensure high cell viability.

All cell batches of ImmunoPure™ PBMCs are rigorously tested to be free from infectious agents and analyzed for cell viability, cell purity, cell count, and CD markers.

ImmunoPure™ PBMCs the latest addition to a comprehensive collection of primary cells supplied by AMSBIO that represent a diverse and heterogeneous population of donors.

As well as a variety of normal human primary cells offered with optimized media, AMSBIO offer viable primary tumour cells from a huge number of cancer types.

Advertisement